Congenital myasthenic syndrome: correlation between clinical features and molecular diagnosis

2021 ◽  
Author(s):  
Eduardo P. Estephan ◽  
Antonio A. Zambon ◽  
Rachel Thompson ◽  
Kiran Polavarapu ◽  
Danny Jomaa ◽  
...  
Keyword(s):  
Clinical Features ◽  
Molecular Diagnosis ◽  
Congenital Myasthenic Syndrome ◽  
Myasthenic Syndrome

scholarly journals Clinical features in a large Iranian family with a limb-girdle congenital myasthenic syndrome due to a mutation in DPAGT1

2013 ◽  
Vol 23 (6) ◽  
pp. 469-472 ◽  
Author(s):  
Keivan Basiri ◽  
Katsiaryna Belaya ◽  
Wei Wei Liu ◽  
Susan Maxwell ◽  
Maryam Sedghi ◽  
...  
Keyword(s):  
Clinical Features ◽  
Congenital Myasthenic Syndrome ◽  
Iranian Family ◽  
Myasthenic Syndrome

scholarly journals Clinical features of congenital myasthenic syndrome due to mutations inDPAGT1

2013 ◽  
Vol 84 (10) ◽  
pp. 1119-1125 ◽  
Author(s):  
Sarah Finlayson ◽  
Jacqueline Palace ◽  
Katsiaryna Belaya ◽  
Timothy J Walls ◽  
Fiona Norwood ◽  
...  
Keyword(s):  
Clinical Features ◽  
Congenital Myasthenic Syndrome ◽  
Myasthenic Syndrome

scholarly journals COVID-19 in a Cohort of Patients with Congenital Myasthenic Syndrome

2021 ◽  
pp. 1-3
Author(s):  
Setareh Alabaf ◽  
Karen O'Connell ◽  
Sithara Ramdas ◽  
David Beeson ◽  
Jacqueline Palace
Keyword(s):  
High Risk ◽  
Neuromuscular Transmission ◽  
Genetic Disorders ◽  
Severe Disease ◽  
Congenital Myasthenic Syndrome ◽  
Referral Centre ◽  
History Of ◽  
Myasthenic Syndrome ◽  
The Uk ◽  
Rare Group

Congenital Myasthenic Syndrome (CMS) are a rare group of genetic disorders of neuromuscular transmission. Some subtypes of CMS can be associated with respiratory and bulbar weakness and these patients may therefore be at high risk of developing a severe disease from COVID-19. We screened 73 patients with genetically confirmed CMS who were attending the UK national referral centre for evidence of previous Severe Acute Respiratory Syndrome Corona Virus 2 infection and their clinical outcome. Of 73 patients, seven had history of confirmed COVID-19. None of the infected patients developed a severe disease, and there were no signals that CMS alone carries a high risk of severe disease from COVID-19.

Combined Muscle Biopsy and Comprehensive Electrophysiology in General Anesthesia is Valuable in Diagnosis of Neuromuscular Disease in Children

2021 ◽  
Author(s):  
Christina E. Hoei-Hansen ◽  
Marie L. B. Tygesen ◽  
Morten Dunø ◽  
John Vissing ◽  
Martin Ballegaard ◽  
...  
Keyword(s):  
Genetic Testing ◽  
Muscle Biopsy ◽  
Neuromuscular Disease ◽  
Genetic Diagnosis ◽  
Congenital Myasthenic Syndrome ◽  
Diagnostic Quality ◽  
Pathogenic Variants ◽  
Combined Use ◽  
Myasthenic Syndrome ◽  
Size Variability

Abstract Aim The diagnostic workup in patients with delayed motor milestones suspected of having either myopathy or a congenital myasthenic syndrome is complex. Our hypothesis was that performance of a muscle biopsy and neurophysiology including stimulated single-fiber electromyography during an anesthetic procedure, combined with genetic testing has a high diagnostic quality. Materials and Methods Clinical and paraclinical data were retrospectively collected from 24 patients aged from 1 month to 10 years (median: 5.2 years). Results Neurophysiology examination was performed in all patients and was abnormal in 11 of 24. No patients had findings suggestive of a myasthenic syndrome. Muscle biopsy was performed in 21 of 24 and was normal in 16. Diagnostic findings included nemaline rods, inclusion bodies, fiber size variability, and type-II fiber atrophy. Genetic testing with either a gene panel or exome sequencing was performed in 18 of 24 patients, with pathogenic variants detected in ACTA1, NEB, SELENON, GRIN2B, SCN8A, and COMP genes. Conclusion Results supporting a neuromuscular abnormality were found in 15 of 24. In six patients (25%), we confirmed a genetic diagnosis and 12 had a clinical neuromuscular diagnosis. The study suggests that combined use of neurophysiology and muscle biopsy in cases where genetic testing does not provide a diagnosis can be useful in children with delayed motor milestones and clinical evidence of a neuromuscular disease.

scholarly journals Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain

2015 ◽  
Vol 97 (6) ◽  
pp. 878-885 ◽  
Author(s):  
Clare V. Logan ◽  
Judith Cossins ◽  
Pedro M. Rodríguez Cruz ◽  
David A. Parry ◽  
Susan Maxwell ◽  
...  
Keyword(s):  
Collagen Type ◽  
Congenital Myasthenic Syndrome ◽  
Syndrome Type ◽  
Fibrillar Collagen ◽  
Myasthenic Syndrome

A novel mutation in the TPR6 domain of the RAPSN gene associated with congenital myasthenic syndrome

2012 ◽  
Vol 316 (1-2) ◽  
pp. 112-115 ◽  
Author(s):  
Esther Leshinsky-Silver ◽  
Daniel Shapira ◽  
Keren Yosovitz ◽  
Mira Ginsberg ◽  
Tally Lerman-Sagie ◽  
...  
Keyword(s):  
Novel Mutation ◽  
Congenital Myasthenic Syndrome ◽  
Myasthenic Syndrome
Sign in / Sign up

Export Citation Format

Share Document